Can't beat bottom line growth for any business, much less a so-called start-up, OTC public company such as ONCI/HEXA ... and this alone indeed makes it unique in this market ... then add to that having in-demand products and best of all in light of being a 'penny' having an ambitious, forthright, hard-working CEO who's publicly declared retiring shares short term and potentially getting a buy-out ... makes this a no-brainer!